Gilead’s Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data esagonowsky Mon, 08/31/2020 – 11:27 More: Gilead's Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data Source: fierce
read moreGlaxoSmithKline eyes novel death-risk reduction update to Trelegy’s label, but analysts say the FDA may not be impressed kblankenship Mon, 08/31/2020 – 10:58 More: GlaxoSmithKline eyes novel death-risk reduction update to Trelegy's label, but analysts say the FDA may not
read moreMylan yanks four lots of heart health, hemophilia injectables over packaging mix-up fkansteiner Mon, 08/31/2020 – 10:55 More: Mylan yanks four lots of heart health, hemophilia injectables over packaging mix-up Source: fierce
read moreEmergent steps to the plate with Major League Baseball and virtual experience for opioid overdose awareness bbulik Mon, 08/31/2020 – 10:42 More: Emergent steps to the plate with Major League Baseball and virtual experience for opioid overdose awareness Source: fierce
read moreFiercePharmaPolitics—FDA would consider COVID vaccines before phase 3 trials finish, commissioner says esagonowsky Mon, 08/31/2020 – 09:42 More: FiercePharmaPolitics—FDA would consider COVID vaccines before phase 3 trials finish, commissioner says Source: fierce
read moreESC: Novartis’ Entresto racks up a heart failure study win—but it’s a mixed one kblankenship Sat, 08/29/2020 – 17:17 More: ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one Source: fierce
read more© 1994 - 2024 B.M. Pharmaceuticals